224
Views
12
CrossRef citations to date
0
Altmetric
Original

Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: A large multicenter comparative study in patients with malignant lymphoma

, , , , , , , , , & , MD, PhD show all
Pages 897-904 | Received 21 Apr 2006, Accepted 13 Feb 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Massimo Martino, Daniele Laszlo & Francesco Lanza. (2014) Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization. Expert Opinion on Biological Therapy 14:6, pages 757-772.
Read now

Articles from other publishers (10)

Katharina Kriegsmann, Michael Rieger, Mark-Alexander Schwarzbich, Sören Sitter, Mark Kriegsmann, Thomas Bruckner, Manfred Hensel, Anthony Dick Ho, Mathias Witzens-Harig & Patrick Wuchter. (2018) Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma. European Journal of Haematology 101:1, pages 12-20.
Crossref
Ignazio MajolinoDereen MohammedDastan HassanFrancesco IpsevichChra AbdullahRebar MohammedAngelo PalmasMarco PossentiDiana NooriDlir AliHarem KaremSalah SalihMichele VaccaClaudia Del FanteAngelo OstuniAndrea FrigatoMaria Speranza MasseiAnnunziata MannaStefania VastaMarcela GabrielMarta VernaAttilio RovelliValentino ConterKosar AliDosti Othman. (2018) Initial Results of Peripheral-Blood Stem-Cell Mobilization, Collection, Cryopreservation, and Engraftment After Autologous Transplantation Confirm That the Capacity-Building Approach Offers Good Chances of Success in Critical Contexts: A Kurdish-Italian Cooperative Project at the Hiwa Cancer Hospital, Sulaymaniyah. Journal of Global Oncology:4, pages 1-8.
Crossref
Katharina Lisenko, Martin Cremer, Mark-Alexander Schwarzbich, Mark Kriegsmann, Anthony D. Ho, Mathias Witzens-Harig & Patrick Wuchter. (2016) Efficient Stem Cell Collection after Modified Cisplatin-Based Mobilization Chemotherapy in Patients with Diffuse Large B Cell Lymphoma. Biology of Blood and Marrow Transplantation 22:8, pages 1397-1402.
Crossref
Sebastian Giebel, Maria Sadus-Wojciechowska, Kazimierz Halaburda, Joanna Drozd-Sokolowska, Agnieszka Wierzbowska, Jacek Najda, Wlodzimierz Mendrek, Malgorzata Sobczyk-Kruszelnicka, Mateusz Nowicki, Jerzy Holowiecki & Tomasz Czerw. (2015) Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group. Annals of Hematology 95:2, pages 263-269.
Crossref
François Lefrère, Dominique Bastit-Barrau, Olivier Hequet, Philippe Bourin, Suzanne Mathieu-Nafissi, Alain Bohbot, Hervé Tilly, Gilles Salles, Christophe Fermé, Valérie Lapierre, Luc Fornecker, Jean-Michel Micléa, Loic Isebaert, Serge Bologna, Olivier Fitoussi, Nicolas Mounier & Corinne Haioun. (2013) Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients. Transfusion 53:1, pages 115-122.
Crossref
Morie A. Gertz. (2010) review: Current status of stem cell mobilization. British Journal of Haematology 150:6, pages 647-662.
Crossref
Leslie J. Marshall & Eugene O. Major. (2010) Molecular Regulation of JC Virus Tropism: Insights into Potential Therapeutic Targets for Progressive Multifocal Leukoencephalopathy. Journal of Neuroimmune Pharmacology 5:3, pages 404-417.
Crossref
Daniele Focosi, Fabrizio Maggi, Elisabetta Andreoli, Letizia Lanini, Luca Ceccherini-Nelli & Mario Petrini. (2009) The role of bone marrow cells for JCV pathogenicity. Journal of Clinical Virology 45:3, pages 230-231.
Crossref
E Copelan, B Pohlman, L Rybicki, M Kalaycio, R Sobecks, S Andresen, R Dean, A Koo, J Chan, J Sweetenham & B Bolwell. (2008) A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma. Bone Marrow Transplantation 43:2, pages 101-105.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:1, pages 46-53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.